NEW YORK (GenomeWeb News) – The US Department of Defense today said it has awarded the Institute for Systems Biology a contract for nearly $7.7 million to use next-generation sequencing to identify biomarkers that predict post-operative sepsis during the asymptomatic phase of infection.

The work is being done for DoD's Defense Threat Reduction Agency and is expected to be completed May 29, 2016, DoD said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.